Form D · Venture Capital Fund

venBio Global Strategic Fund, L.P.

San Francisco, CA · CIK 0001504130

Offering snapshot reported Oct 29, 2013 · SEC filing

Reported sold: $177M
Investors reported: 4
Minimum accepted: $0
First sale: Nov 3, 2010

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 29, 2013	Amendment	$177,000,000	$0vs Oct 31, 2012	4	SEC filing
Oct 31, 2012	Amendment	$177,000,000	$2,000,000vs Nov 3, 2011	4	SEC filing
Nov 3, 2011	Amendment	$175,000,000	$100,000,000vs Nov 12, 2010	3	SEC filing
Nov 12, 2010	Initial	$75,000,000	No comparison	1	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-150376

Source: Form D, filed Oct 29, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

VENBIO GLOBAL STRATEGIC FUND, L.P.

Investment adviser: VENBIO PARTNERS LLC

Gross asset value: $1.79M
Beneficial owners: 1
ADV minimum commitment: $0

Reported in Form ADV on Mar 12, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator STANDISH MANAGEMENT SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Custodian MORGAN STANLEY & CO. LLC SAN FRANCISCO, California, United States Related to adviser: No

Custodian SILICON VALLEY BANK SAN FRANCISCO, California, United States Related to adviser: No

Provider details

Annual audit: No
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

MORGAN STANLEY & CO. LLC
SEC 8-15869

SILICON VALLEY BANK
LEI 0K2D5AK28E3O5CC06E35

Filing source

Form ADV 2064569 · Mar 12, 2026 · Schedule D 7.B.(1), fund 805-3251864469

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Related funds

Funds whose names form a numbered series with this one and that share its city or the name of a related person. Form D does not state how these funds are related.

Fund	Latest Form D	Reported sold	Investors
venBio Global Strategic Fund, L.P. (this fund)	Oct 29, 2013	$177,000,000	4
venBio Global Strategic Fund II L.P.	Mar 2, 2017	$337,000,000	31
venBio Global Strategic Fund III, L.P.	Mar 26, 2020	$386,055,000	100
venBio Global Strategic Fund IV, L.P.	May 14, 2021	$549,936,000	147
venBio Global Strategic Fund V, L.P.	Jul 12, 2024	$504,700,000	162

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Robert Adelman	Director
Paul Brooke	Director
Corey Goodman	Director
N/A Ven Bio Global Strategic Gp, L.P.	Director
N/A Ven Bio Global Strategic Gp, Ltd.	Director
Kurt Von Emster	Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

1700 Owens Street, Suite 595
San Francisco, CA, 94158